Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier.

Organisations Organisation Sensorion S.A. (Euronext Alternext: ALSEN)
  Organisation 2 Aquilo Capital Management
Products Product SENS-501 gene therapy (OTOF-GT) (Sensorion)
  Product 2 investment banking
Index term Index term Sensorion–SEVERAL: investment, 202402 reserved offering €50.5m with 88.6m new ordinary shares at €0.57/share to existing + new investors
Person Person Ouzren, Nawal (Sensorion 201905 CEO)
     


   
Record changed: 2024-03-14

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Sensorion S.A. (Euronext Alternext: ALSEN)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top